BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6300693)

  • 21. Cholecystokinin-33 inhibits meal size and prolongs the subsequent intermeal interval.
    Washington MC; Coggeshall J; Sayegh AI
    Peptides; 2011 May; 32(5):971-7. PubMed ID: 21335043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibition of tail-pinch-induced food intake by cholecystokinin octapeptides and their fragments.
    Telegdy G; Kádár T; Kovács K; Penke B
    Life Sci; 1984 Jul; 35(2):163-70. PubMed ID: 6330485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
    Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M
    Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin: a putative satiety signal.
    Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):135-8. PubMed ID: 1226392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic administration of cholecystokinin (CCK) inhibits operant water intake in rats: implications for the CCK-satiety hypothesis.
    Ebenezer IS
    Proc Biol Sci; 1996 Apr; 263(1369):491-6. PubMed ID: 8637930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake.
    Lo CM; Zhang DM; Pearson K; Ma L; Sun W; Sakai RR; Davidson WS; Liu M; Raybould HE; Woods SC; Tso P
    Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1490-4. PubMed ID: 17634201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats.
    West DB; Fey D; Woods SC
    Am J Physiol; 1984 May; 246(5 Pt 2):R776-87. PubMed ID: 6326618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin-8 increases the satiety ratio in diabetic rats more than cholecystokinin-33.
    Larsen CJ; Washington MC; Sayegh AI
    Physiol Behav; 2010 Dec; 101(5):649-52. PubMed ID: 20869975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of central and peripheral cholecystokinin in mediating appetitive behaviors.
    Crawley JN; Rojas-Ramirez JA; Mendelson WB
    Peptides; 1982; 3(3):535-8. PubMed ID: 6289285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human satietin: rapid development of tolerance and its specificity to feeding behavior in rats.
    Mendel VE; Benitez RR; Tetzke TA
    Pharmacol Biochem Behav; 1988 Sep; 31(1):21-6. PubMed ID: 3252253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of continuous infusions of CCK-8 on food intake and body and pancreatic weights in rats.
    Lukaszewski L; Praissman M
    Am J Physiol; 1988 Jan; 254(1 Pt 2):R17-22. PubMed ID: 3337268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ileal interposition attenuates the satiety responses evoked by cholecystokinin-8 and -33.
    Metcalf SA; Washington MC; Brown TA; Williams CS; Strader AD; Sayegh AI
    Peptides; 2011 Jun; 32(6):1296-302. PubMed ID: 21557974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effect of CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin on food intake regulation in lean mice.
    Maletínská L; Maixnerová J; Matysková R; Haugvicová R; Pirník Z; Kiss A; Zelezná B
    BMC Neurosci; 2008 Oct; 9():101. PubMed ID: 18939974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated injections of lipopolysaccharide attenuate the satiety effects of cholecystokinin.
    Cross-Mellor SK; Kavaliers M; Ossenkopp KP
    Neuroreport; 1999 Dec; 10(18):3847-51. PubMed ID: 10716221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ineffectiveness of cholecystokinin in impairing runway performance.
    Cox JE; Brown PT; Toney RJ; Wiebe DJ
    Behav Brain Res; 1984 Oct; 14(1):41-50. PubMed ID: 6097286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feeding-suppressive mechanism of sulfated cholecystokinin (26-33) in chicks.
    Tachibana T; Matsuda K; Kawamura M; Ueda H; Khan MS; Cline MA
    Comp Biochem Physiol A Mol Integr Physiol; 2012 Apr; 161(4):372-8. PubMed ID: 22227312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of acute satiety response to cholecystokinin in pregnant rats.
    Ladyman SR; Sapsford TJ; Grattan DR
    J Neuroendocrinol; 2011 Nov; 23(11):1091-8. PubMed ID: 21771116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraperitoneal, but not subcutaneous, administration of the sulphated cholecystokinin octapeptide (CCK-8S) inhibits operant and nonoperant food intake in rats: implications for the CCK-satiety hypothesis.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):167-71. PubMed ID: 10389118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin.
    Crawley JN; Kiss JZ
    Peptides; 1985; 6(5):927-35. PubMed ID: 4080609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain regions where cholecystokinin suppresses feeding in rats.
    Blevins JE; Stanley BG; Reidelberger RD
    Brain Res; 2000 Mar; 860(1-2):1-10. PubMed ID: 10727618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.